Cost-effectiveness of Ledipasvir/Sofosbuvir in Chronic HCV Cost-effectiveness of Ledipasvir/Sofosbuvir in Chronic HCV

This study assessed the cost-effectiveness of LDV/SOF therapy in treatment-naive patients with absence or mild fibrosis vs. patients with significant or advanced fibrosis.Journal of Viral Hepatitis
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news